title: Evolving role of theophylline for treatment of chronic childhood asthma.
authors.affiliation: National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA.
authors.forename: S J
authors.initials: SJ
authors.lastname: Szefler
authors.forename: B G
authors.initials: BG
authors.lastname: Bender
authors.forename: W J
authors.initials: WJ
authors.lastname: Jusko
authors.forename: B Q
authors.initials: BQ
authors.lastname: Lanier
authors.forename: R F
authors.initials: RF
authors.lastname: Lemanske
authors.forename: D P
authors.initials: DP
authors.lastname: Skoner
authors.forename: D A
authors.initials: DA
authors.lastname: Stempel
mesh_terms: D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001507:Beclomethasone / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006801:Humans; D009921:Metaproterenol / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013806:Theophylline / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D009921:Metaproterenol; D013806:Theophylline; D001507:Beclomethasone; D004205:Cromolyn Sodium